Find verified Cre 16257 API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Cre 16257 for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Cre 16257 API.
Alternate Names: EML-257, (+/-)-, CRE-16257, (+/-)-
CAS No: 203855-56-5
PubChem CID: 9828950
Mol Formula: C17H15FO3
Mol Weight: 286.30 g/mol
IUPAC Name: 2-benzyl-4-(4-fluorophenyl)-4-oxobutanoic acid
Commercial / Development Status: Unknown/Inactive APIs
Source / Manufacturing Origin: Synthetic APIs
API Description: CRE-16257 is a discontinued drug candidate that was a B-cell stimulant and insulin sensitizer, initially developed by Merck & Co.. The designation "CRE" can also refer to Carbapenem-Resistant Enterobacteriaceae, which are a significant cause of hospital-acquired infections and are resistant to a class of antibiotics known as carbapenems.
